Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
72 studies found for:    Hereditary Neuropathies
Show Display Options
Rank Status Study
21 Withdrawn Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
Condition: Leber's Hereditary Optic Neuropathy
Interventions: Drug: Idebenone;   Drug: Placebo
22 Recruiting Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
23 Enrolling by invitation Natural History in CCFDN and IBM Syndromes
Conditions: Inclusion Body Myositis, Sporadic;   Inclusion Body Myopathy, Autosomal-recessive;   Inclusion Body Myopathy, Autosomal-dominant;   Congenital Cataracts, Facial Dysmorphism, And Neuropathy
Intervention: Other: Natural History
24 Recruiting Study of Inherited Neurological Disorders
Conditions: Ataxia;   Motor Neuron Disease;   Muscular Disease;   Muscular Dystrophy;   Peripheral Nervous System Disease
Intervention:
25 Completed
Has Results
Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
Condition: Familial Amyloid Polyneuropathy
Interventions: Drug: Fx-1006A;   Drug: Placebo
26 Completed
Has Results
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
Conditions: Familial Amyloid Polyneuropathy;   ATTR-PN
Intervention: Drug: Fx-1006A
27 Unknown  Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Conditions: Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: TreSPE;   Other: SPE
28 Completed Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
Conditions: Optic Atrophy;   Non-arteritic Anterior Ischemic Optic Neuropathy
Intervention: Drug: QPI-1007 at various doses
29 Recruiting Stem Cell Ophthalmology Treatment Study
Conditions: Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
Interventions: Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
30 Completed Phenotype/Genotype Correlations in Neuromuscular Disorders
Condition: Neuromuscular Disease
Intervention:
31 Completed Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Conditions: Arteriovenous Malformation;   Hereditary Hemorrhagic Telangiectasia;   Hematochezia;   Melena
Intervention: Drug: Thalidomide
32 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
33 Not yet recruiting Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Type 1A Neuropathy
Intervention:
34 Recruiting Influence of Pronator Teres Release on Treatment of Median Nerve Compression Neuropathy
Condition: Median Nerve Compression
Interventions: Procedure: Pronator Teres Release;   Procedure: dual compression release;   Procedure: median nerve release only
35 Recruiting The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia
Condition: Familial Dysautonomia
Intervention: Dietary Supplement: Kinetin
36 Completed The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome
Condition: Compression Neuropathy, Carpal Tunnel
Intervention: Procedure: Ischemic Compression (thumb Pressure)
37 Terminated Giant Axonal Neuropathy Natural History Study
Condition: Giant Axonal Neuropathy
Intervention:
38 Completed Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
Condition: Familial Dysautonomia
Interventions: Drug: Carbidopa;   Drug: Placebo
39 Completed Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Conditions: Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Amyotrophic Lateral Sclerosis
Intervention:
40 Not yet recruiting Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
Conditions: Carpal Tunnel Syndrome;   Compression Neuropathy
Interventions: Drug: Acetyl-l-carnitine;   Drug: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years